Global Vinpocetine Injection Market Size, Share, and Trends Analysis Report, By Type (10 mg and 30 mg), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Forecast (2022-2028)

The global vinpocetine injection market is anticipated to grow at a CAGR of 3.5% during the forecast period (2022- 2028). Vinpocetine (ethyl apovincaminate) is a synthetic derivative of the vinca alkaloid vincamine derived from the Voacanga Africana seeds or the Vinca minor leaves also known as periwinkles. Vinpocetine Injection is used to enhance memory and increase brain metabolism. It has also been used for ischemia and reperfusion injury and is considered a neuroprotective agent. It is also used in the treatment of Alzheimer’s disease, stroke, dementia in Parkinson’s disease, age-related memory loss, and head injury. Vinpocetine has been clinically indicated for the treatment of cerebrovascular disorders such as stroke and dementia. These are some of the factors that are driving then the growth of the global vinpocetine injection market. However, the limited standard clinical research showing vinpocetine’s effectiveness against slow growth of brain or dementia and the availability of alternative medications to vinpocetine may restrain the growth of the market.

The market is segmented based on the type and application. Based on the type, the market is sub-segmented into 10mg and 30mg. 10 mg injection is used to treat diseases such as Alzheimer’s disease, that interfere with thinking (dementia). 30 mg Injection is used to raise blood pressure in hypotensive (low blood pressure) states, such as following spinal anesthesia. It increases the blood pressure rapidly by increasing the pumping capacity of the heart and narrowing the blood vessels of the heart. Some major companies in the market include Sun Pharmaceutical Industries Ltd., and Micro Labs Ltd. (Synapse) among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Sun Pharmaceutical Industries Ltd., and Micro Labs Ltd. (Synapse) among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Vinpocetine Injection Market Report by Segment

By Type

• 10 mg
• 30 mg

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Vinpocetine Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa